We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Prolacta Bioscience®, the world's leading hospital provider of 100% human milk-based nutritional products, today announced results of an interim subgroup analysis of a prospective observational study.